Annapolis Infectious Disease Associates Llp | |
1127 West St Ste 105 Annapolis MD 21401-4284 | |
(410) 573-9511 | |
(410) 573-4816 |
Full Name | Annapolis Infectious Disease Associates Llp |
---|---|
Speciality | Internal Medicine |
Location | 1127 West St Ste 105, Annapolis, Maryland |
Authorized Official Name and Position | David Barnes (PARTNER) |
Authorized Official Contact | 4105739511 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Annapolis Infectious Disease Associates Llp Po Box 9689 Arnold MD 21012-0689 Ph: (410) 573-9511 | Annapolis Infectious Disease Associates Llp 1127 West St Ste 105 Annapolis MD 21401-4284 Ph: (410) 573-9511 |
NPI Number | 1427259654 |
---|---|
Provider Enumeration Date | 05/28/2007 |
Last Update Date | 09/13/2022 |
Medicare PECOS PAC ID | 0941394373 |
---|---|
Medicare Enrollment ID | O20070917000278 |
News Archive
In a recent New York Times opinion column, dietitian Christy Harrison, an "intuitive eating coach" and author, responded to a fellow clinician who had questioned some of her thoughts on the link between being overweight and developing other medical conditions.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
A team of Russian scientists identified the role of the interleukin-6 molecule in the development of allergic asthma. Now it can be a new target for the treatment of this disease. The results are published in Frontiers in Immunology.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1427259654 | NPI | - | NPPES |
214005500 | Medicaid | MD | |
R996 | Other | DC | CAREFIRST BCBS |
LK63AN | Other | MD | CAREFIRST BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | (* (Not Available)) | Primary |
Provider Name | Kambayanda S Chengappa |
---|---|
Provider Type | Practitioner - Infectious Disease |
Provider Identifiers | NPI Number: 1790829729 PECOS PAC ID: 8628041076 Enrollment ID: I20070917000294 |
News Archive
In a recent New York Times opinion column, dietitian Christy Harrison, an "intuitive eating coach" and author, responded to a fellow clinician who had questioned some of her thoughts on the link between being overweight and developing other medical conditions.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
A team of Russian scientists identified the role of the interleukin-6 molecule in the development of allergic asthma. Now it can be a new target for the treatment of this disease. The results are published in Frontiers in Immunology.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
› Verified 9 days ago
Provider Name | Ellen Yang |
---|---|
Provider Type | Practitioner - Infectious Disease |
Provider Identifiers | NPI Number: 1912955873 PECOS PAC ID: 8921192352 Enrollment ID: I20101109001482 |
News Archive
In a recent New York Times opinion column, dietitian Christy Harrison, an "intuitive eating coach" and author, responded to a fellow clinician who had questioned some of her thoughts on the link between being overweight and developing other medical conditions.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
A team of Russian scientists identified the role of the interleukin-6 molecule in the development of allergic asthma. Now it can be a new target for the treatment of this disease. The results are published in Frontiers in Immunology.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
› Verified 9 days ago
Provider Name | David Barnes |
---|---|
Provider Type | Practitioner - Infectious Disease |
Provider Identifiers | NPI Number: 1336197920 PECOS PAC ID: 7012001449 Enrollment ID: I20101115000024 |
News Archive
In a recent New York Times opinion column, dietitian Christy Harrison, an "intuitive eating coach" and author, responded to a fellow clinician who had questioned some of her thoughts on the link between being overweight and developing other medical conditions.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
A team of Russian scientists identified the role of the interleukin-6 molecule in the development of allergic asthma. Now it can be a new target for the treatment of this disease. The results are published in Frontiers in Immunology.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
› Verified 9 days ago
Provider Name | Ryan S Arnold |
---|---|
Provider Type | Practitioner - Infectious Disease |
Provider Identifiers | NPI Number: 1255533154 PECOS PAC ID: 7517120553 Enrollment ID: I20120531000418 |
News Archive
In a recent New York Times opinion column, dietitian Christy Harrison, an "intuitive eating coach" and author, responded to a fellow clinician who had questioned some of her thoughts on the link between being overweight and developing other medical conditions.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
A team of Russian scientists identified the role of the interleukin-6 molecule in the development of allergic asthma. Now it can be a new target for the treatment of this disease. The results are published in Frontiers in Immunology.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
› Verified 9 days ago
Provider Name | Michael Thompson |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1629462080 PECOS PAC ID: 7618272618 Enrollment ID: I20200810002040 |
News Archive
In a recent New York Times opinion column, dietitian Christy Harrison, an "intuitive eating coach" and author, responded to a fellow clinician who had questioned some of her thoughts on the link between being overweight and developing other medical conditions.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
A team of Russian scientists identified the role of the interleukin-6 molecule in the development of allergic asthma. Now it can be a new target for the treatment of this disease. The results are published in Frontiers in Immunology.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
› Verified 9 days ago
News Archive
In a recent New York Times opinion column, dietitian Christy Harrison, an "intuitive eating coach" and author, responded to a fellow clinician who had questioned some of her thoughts on the link between being overweight and developing other medical conditions.
Before the huge potential of tiny nanocarriers for highly targeted drug delivery and environmental clean-up can be realized, scientists first need to be able to see them.
A team of Russian scientists identified the role of the interleukin-6 molecule in the development of allergic asthma. Now it can be a new target for the treatment of this disease. The results are published in Frontiers in Immunology.
The Cancer Prevention and Research Institute of Texas (CPRIT) released five cancer research requests for applications (RFA) just three months after receiving its first funding. In May, 2009, the 81st Legislature appropriated $450 million dollars in bond proceeds for the next two years for CPRIT to fund cancer research and prevention grants that will expedite innovation in cancer treatment and expand cancer prevention services in the state.
› Verified 9 days ago
Luminis Health Primary Care Ginger Cove Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4000 River Crescent Dr, Annapolis, MD 21401 Phone: 443-481-1000 | |
Premier Mri Services Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 107 Ridgley Ave, Suite 12, Annapolis, MD 21401 Phone: 410-267-1780 Fax: 410-267-1784 | |
Annapolis Psychological Services, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 512 State St, Annapolis, MD 21403 Phone: 667-401-7710 | |
Chesapeake Digestive Associates, Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 621 Ridgely Ave Ste 201, Annapolis, MD 21401 Phone: 410-224-4887 Fax: 410-224-1428 | |
The Retina Group Of Washington, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2002 Medical Pkwy Ste 450, Annapolis, MD 21401 Phone: 410-224-6680 Fax: 800-762-2852 | |
Dr. Nancy's Housecalls Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1209a Marda Ln, Annapolis, MD 21403 Phone: 410-353-9323 Fax: 410-741-3870 | |
Jack R Lichtenstein, Md Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 205 Ridgely Ave, Annapolis, MD 21401 Phone: 410-263-6910 Fax: 443-433-0456 |